Status:
COMPLETED
Investigation of Critically Ill Patients With Newly Diagnosed Diabetes
Lead Sponsor:
Stamford Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to investigate the clinical outcomes and glucose control metrics of critically ill patients with previously undiagnosed diabetes compared to those with known diabetes at t...
Detailed Description
This case control study compares previously undiagnosed diabetic patients (defined as HbA1c \> 6.5% and no history of diabetes), to those with known diabetes, using 1:1 matching. Patients met inclusio...
Eligibility Criteria
Inclusion
- 20
- Patients admitted between 9/14/2011 and 11/30/19 with HbA1c available on admission and at least four documented blood glucose tests during their ICU stay.
Exclusion
- Patients admitted for diabetic ketoacidosis.
- Patients admitted to the ICU following cardiovascular surgery.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
1777 Patients enrolled
Trial Details
Trial ID
NCT05256043
Start Date
January 1 2011
End Date
January 1 2022
Last Update
February 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stamford Health
Stamford, Connecticut, United States, 06902